“The uMotif digital health platform helps people lead healthy and independent lives, supported by their clinicians and carers through engaging, beautiful and effective software that improves health treatments, saves lives and reduces costs.
“Our mobile and web apps combine patient-led data inputs, passive sensor data (from the Internet of Everything), health open data sets and a range of engaging content to help patients better self-manage their health. We provide clinicians with simple, powerful and relevant portals to view, manage and stratify their patient groups, improving the process of shared decision making.
“Through our B2B2C SaaS platform, we deliver quantified and evidence-backed improvements in the care of Long Term Conditions and Post-Operative recovery.
“We have completed an initial trial in Parkinson’s Disease, currently being written up by the University of London to present at the World Parkinson’s Congress in October. Our mobile app achieved 70% daily “use rates and a statistically significant increase in patient adherence to medication. We have secured funding for a multi-centre trial in NHS centres across the UK.
“Our diabetes products will be trialled in 2,000 patients across 4 NHS organisations in late 2013; and we are currently assessing a product for post-operative care at the Barts and Royal London Hospitals.
“uMotif was selected to join two UK Trade Missions to India (February 2013) and USA (September 2012), both of which have resulted in a number of international expansion opportunities.”
Photograph: Ben James- Co-founder & Chief Designer, Dr. Rashmi Narayana- Clinical & Evidence Director and Bruce Hellman - Co-founder
Questions we asked the Cisco startups: